Imagion Biosystems September 2021 Investor Newsletter

Imagion Biosystems is pleased to provide its investors with its September 2021 Investor Newsletter.

The newsletter details recent new company developments and activities, including:

  • Message from the CEO, Mr Robert Proulx;
  • Q&A with Jane Fox, Director of Breast Services at Monash Health, and Principal Investigator of the

    MagSense® HER2 breast cancer clinical study;

  • Expanding the MagSense® pipeline to brain cancer;
  • IBX SAB member Dr Andrew Scott Appointed to VCCC Alliance;
  • Imagion Biosystems 1H2021 Half-Year Report;
  • Employment of Chief Development Officer; and
  • Update on Nanoparticle Sales.

    Imagion Biosystems normally distributes this update as an e-newsletter. Investors can sign up to receive email updates at this link: http://ems.gs/3FuT0frcGxD

Please click to review the newsletter at ASX.